Related Experiment Videos
[Pancreatic sarcoidosis]
M Robaszkiewicz1, J M Cauvin, J B Nousbaum
1Service d'Hépato-Gastroentérologie Charles-Debray, Brest.
Abstract:
The authors report the case of a 30 year-old man with previous history of sarcoidosis, who presented with a painful infiltration of the pancreas. A review of the literature showed that symptomatic pancreatic sarcoidosis was uncommon, since only 8 other cases have been reported. Pancreatic involvement is frequently associated with hepatic infiltration (5/6 cases). Exocrine or endocrine dysfunction are possible. Diagnosis is made only at exploratory laparotomy. Prognosis is good. Steroid therapy is indicated in this peculiar type of pancreatitis, because of its long-range effectiveness on the outcome of the disease.
Insights
Symptomatic pancreatic sarcoidosis is rare, with only 9 reported cases. This condition, often linked with liver involvement, typically requires exploratory surgery for diagnosis but has a good prognosis with steroid therapy.
Area of Science:
- Gastroenterology
- Immunology
- Oncology
Background:
- Sarcoidosis is a multisystem granulomatous disease of unknown etiology.
- Pancreatic involvement in sarcoidosis is rare, particularly symptomatic cases.
Observation:
- A 30-year-old man with a history of sarcoidosis presented with painful pancreatic infiltration.
- Literature review identified only 8 previously reported cases of symptomatic pancreatic sarcoidosis.
Findings:
- Pancreatic sarcoidosis is often associated with hepatic infiltration (5/6 cases).
- Potential complications include exocrine or endocrine dysfunction.
- Diagnosis is typically confirmed via exploratory laparotomy.
Implications:
- Pancreatic sarcoidosis, though rare, should be considered in patients with a history of sarcoidosis and pancreatic symptoms.
- Prognosis is generally favorable.
- Steroid therapy is recommended for its long-term effectiveness in managing pancreatic sarcoidosis.